Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholder's Equity (Tables)

Stockholder's Equity (Tables)

6 Months Ended

May. 31, 2015

Significant Option Groups Outstanding and Exercisable Option and its Price and Contractual Life

Significant option groups outstanding and exercisable at May 31, 2015 and related price and contractual life information are as follows:


	Outstanding						Exercisable
Range of Exercise Prices	Outstanding		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Outstanding		Weighted Average Exercise Price
$0.42 to $1.00		2,500		0.21	$	0.68		2,500	$	0.68
$1.01 to $ 2.00		466,764		5.98	$	1.72		465,931	$	1.72
$2.01 to $ 3.00		515,500		4.90	$	2.53		507,997	$	2.53

		984,764		5.40	$	2.14		976,428	$	2.14

Summary of Non-Vested Options

A summary of the status of the Company’s non-vested options as of May 31, 2015, and changes during the six months ended May 31, 2015, is presented below:


	Shares			Weighted Average Grant-Date Fair Value
Non-vested at November 30, 2014		27,083		$	1.64

Granted		—			—
Vested		(18,747	)		1.66
Forfeited		—			—

Non-vested at May 31, 2015		8,336		$	1.59

Service-Based Vesting Condition Options [Member]

Stock Option Activity for Options

Stock option activity for options with only service-based vesting conditions for the six months ended May 31, 2015, was as follows:


	Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value
Outstanding at November 30, 2014		997,266		$	2.14		5.84	$	661,466

Granted		—							—
Exercised		—			—				—
Expired/forfeited		(12,502	)		2.09				3,409

Outstanding at May 31, 2015		984,764		$	2.14		5.40	$	348,536

Exercisable at May 31, 2015		976,428		$	2.14		5.40	$	348,069